Product Information

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1351 per EA under NDC 43386035610. Its NADAC has been published 452 times since Nov 1, 2017.

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1351per EA
DEA Schedule CII

Strength

325; 5 mg/1; mg/1

NDC

43386035610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206245

On Market Since

12/1/2016

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 452 times since Nov 1, 2017, and over the history we have for it it has risen 21.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1351 per EA
All-time high$0.1518 (Jul 10, 2024)
All-time low$0.0764 (Nov 20, 2019)
52-week high$0.1351
52-week low$0.1273
Median price$0.1056
Average price$0.1090
Largest weekly change+33.6% (Jan 22, 2020)
Weeks tracked452
Tracking sinceNov 1, 2017

Price History

1W

0.0%

1M

+3.1%

3M

+4.8%

6M

+4.1%

1Y

+2.7%

3Y

+19.8%

5Y

+47.3%

All

+21.0%

Generic Alternatives

The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1351 per EA (NDC 43386035610), effective Jun 24, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has risen 21.0%. It has been tracked across 452 weekly CMS publications since Nov 1, 2017.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Since Nov 1, 2017, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.0764 (Nov 20, 2019) to a high of $0.1518 (Jul 10, 2024), with a median of $0.1056 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.1066 per EA — about 21% below HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 43386035610) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.